NCPA to Testify on ACA Individual Mandate before House Ways & Means Committee

On January 24, 2017, in the first meeting of the House Ways & Means Subcommittee on Oversight, NCPA Senior Fellow John R. Graham will testify on “Examining the Effectiveness of the Individual Mandate under the ACA” to the House Committee on Ways & Means. John Graham is one of the leading healthcare experts in the country and has written extensively on Obamacare and other healthcare policies. The theme of his testimony will be that Obamacare’s “Individual Mandate” is economically inefficient and does not improve access to healthcare.

Regulations Are A Really Big Drag On U.S. Growth

Townhall: The cumulative buildup of federal regulations over time leads to duplicative, obsolete, conflicting and even contradictory rules which stifle growth, says AEI Resident Scholar Mark Perry and NCPA Senior Fellow Thomas Hemphill in this commentary at Investor’s Business Daily.

Debating the Death of the American Dream

InsideSources: Is the American Dream lost? “No”, says NCPA Director of Youth Programs Rachel Stevens in an InsideSources commentary. Stevens argues that establishing debate-based education in America’s schools will improve students’ critical thinking skills and awareness of important political issues, ensuring the health and survival of the American Dream.

Op-ed: Rethink Pell Grants for prisoners

Campus News: In this Campus News commentary, NCPA Senior Research Fellow Lloyd Bentsen IV explains that while it is good that states are looking to reduce their prison costs by increasing access to education, increasing Pell Grants eligibility is not the way to go. 

Should Drug Patents Apply in Poor Countries?

Real Clear Policy: In light of the World Trade Organization’s upcoming discussion of current patent exemptions, NCPA Senior Fellow Thomas A. Hemphill discusses the intellectual property benefits and concerns associated with drug patents in least developed countries in a Real Clear Policy commentary.